What SHARx does

SHARx (SHARx LLC), founded in 2017 and headquartered in St. Louis, Missouri, is a privately held pharmacy procurement and advocacy company that helps self-funded employers and their employees access high-cost specialty medications outside traditional insurance and PBM channels. Its core product is a procurement and supply chain management solution that sources brand-name, FDA-approved medications through domestic and international supply chains (including Canada), supported by a dedicated staff of advocates and an on-staff pharmacist. SHARx also operates a proprietary member portal where members can view medication information, communicate with advocates, and track prescriptions.

The company monetizes via a flat, predictable per-employee-per-month (PEPM) fee charged to employers — a structure designed so that SHARx does not profit from higher drug costs, in contrast to spread-based PBM economics. Go-to-market is built around three reinforcing channels: a broker/benefits-consultant network (the "Rising Tides Army" — 246 brokerages and 375 brokers), direct enterprise sales to self-funded employers emphasizing fiduciary and PBM-transparency narratives, and a grassroots/community-led motion featuring WNBA, NFL, and PGA brand ambassadors. Customers include 1,025+ self-funded employers across 45 states, with cumulatively 780,000+ members served and over $1.14B in medications sourced since inception.

SHARx does not publish financials, has no disclosed funding history, and operates as a founder-led LLC (Corey Durbin, CEO; Paul Pruitt, CGO; Joe Reddy, CTO; Eric DuBois, COO). The company's growth is anchored in a mission-driven narrative tied to co-founder Paul Pruitt's personal experience with two sons requiring medications costing nearly $2.5M/year per child. Operational risks include a pending lawsuit from Genentech and Novartis over Canadian-imported Xolair shipments alleging cold-chain failures — a precedent that could materially affect the international sourcing model.

Name

SHARx

Legal name

SHARx LLC

Website

https://sharxplan.com

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

101–250 employees

Short description

SHARx is a private, St. Louis–based pharmacy procurement and advocacy company founded in 2017 that uses non-insurance, flat per-employee-per-month pricing to help self-funded employers and their members access high-cost specialty medications via global sourcing and dedicated clinical advocates.

Ownership category

akta.pro rank

Product category

Pharmacy Benefit Procurement Services

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

International Reference Pricing (IRP) & External Price Benchmarking (HLAIAKAF)

Keywords

• Specialty medication procurement
• Pharmacy benefit management
• Prescription cost containment
• Self-funded employer benefits
• Global drug sourcing

Headquarters

HQ city

St Louis

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Supply Chain, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Per-Employee-Per-Month (PEPM) Fees: SHARx charges employers a flat, predictable per-employee-per-month fee regardless of which medications are needed. This creates alignment between SHARx and employer interests—the company is not incentivized to rely on any particular sourcing option and clients do not pay more when employees need expensive medications.
2. Procurement Services for High-Cost Medications: Revenue generated through sourcing high-cost and specialty medications from domestic and international supply chains. The company uses non-insurance sourcing methods to find medications at the lowest possible prices, with the fee structure designed to keep incentives aligned.

Pricing tiers

Go-to-market motion4 records

Distribution channels4 records

Marketing channels8 records

Core offering

SHARx is a non-insurance procurement and supply chain management solution that helps self-funded employers and their members access high-cost specialty and brand-name prescription medications at reduced prices. The company uses domestic and international sourcing, including imports from Canada, combined with a flat per-employee-per-month (PEPM) fee model and a member portal supported by clinical advocates to navigate prior authorizations, formulary exclusions, and pricing barriers.

Product overview

SHARx is a prescription drug procurement management solution that operates as a unified platform combining technology-enabled member services with advocacy support. The core offering consists of the SHARx Core Platform—a procurement and supply chain management solution for high-cost prescription drugs—complemented by the Member Portal (an intuitive online interface for medication management and advocate communication) and Advocate Services (compassionate clinical support). SHARx also runs the Rising Tides Army, a grassroots advocacy community, and the Rising Tides Podcast for industry education. The company uses non-insurance sourcing methods and flat-fee pricing to provide transparent, predictable access to specialty medications for employers and their employees.

Differentiator

Problem solved

Functional benefit

Products and services

• SHARx Core Platform A procurement and supply chain management solution for high-cost prescription drugs that helps employers navigate the complex market of specialty medications using non-insurance sourcing methods, providing flat-fee pricing and global procurement to ensure members access essential medications at the lowest possible price.
• Member Portal An intuitive online platform that allows members to manage their medications, track savings, communicate with advocates, and access prescription information through streamlined onboarding and white-glove service.
• Advocate Services Dedicated team of experienced, compassionate advocates including on-staff clinical staff who provide ongoing support to members and work directly with providers to ensure members receive prescribed medications and access to care.

Quantifiable outcome

• Medication costs reduced from $734 to $20 for individual members
• +4 more outcomes

Named customers5 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• JOTO PR DisruptorssupportingGTM or Marketing Partner · 11 December 2025SHARx engaged JOTO PR Disruptors in December 2025 to promote prescription cost reform in the U.S. The campaign highlights SHARx's transparent and affordable medication model amidst rising drug costs and opaque pricing.

Scale indicators8 records

Recent moves5 records

Expansion highlights5 records

Emerging players

• Rightway: Rightway provides pharmacy navigation and member advocacy services that help employees access medications more affordably, overlapping with SHARx's white-glove advocacy and member portal. While not a PBM, it competes for employer budget allocation on specialty drug management.
• Cost Plus Drugs (Mark Cuban Cost Plus Drug Company): Cost Plus Drugs offers transparent, cost-plus pricing on a rapidly expanding formulary, attacking the same opaque US drug pricing problem SHARx addresses. While direct-to-consumer today, its expansion into employer-channel benefits creates partial overlap with SHARx's employer value proposition.

Direct peers

• Capital Rx: Capital Rx operates a transparent, pass-through PBM (Judi) that eliminates spread pricing and aligns incentives with employers, very similar to SHARx's flat-fee, non-spread model. Both target self-funded employers frustrated by traditional PBM economics, making them direct competitors in the transparent PBM category.
• True Rx Management: True Rx Management is a transparent, pass-through PBM serving self-funded employers with aligned-incentive economics closely mirroring SHARx's model. It competes directly for broker-distributed employer business and emphasizes fiduciary-grade pharmacy benefit management.
• EmpiRx Health: EmpiRx Health is a clinically driven PBM using a value-based, aligned-incentive model to manage specialty drug spend for self-funded employers. It serves the same customer segment as SHARx and competes on transparency and outcome-based pricing.
• SmithRx: SmithRx is a transparent, technology-forward PBM purpose-built for self-funded employers with a flat per-member-per-month pricing model analogous to SHARx's PEPM structure. It competes head-to-head with SHARx for the same broker-distributed, self-funded employer accounts.
• RxBenefits: RxBenefits is a PBM optimizer and procurement partner that works through benefit brokers and consultants to help self-funded employers control prescription drug spend. Both companies operate in the broker-distributed employer pharmacy procurement space with aligned-incentive language.

Broad incumbents

• Express Scripts (Evernorth): Express Scripts is one of the three largest U.S. PBMs and the primary incumbent SHARx positions against in its marketing. Its legacy spread-pricing model and large employer footprint define the status quo SHARx is disrupting for self-funded plans.
• Optum Rx (UnitedHealth Group): Optum Rx is the largest U.S. PBM by script volume and part of UnitedHealth Group's integrated payer-provider-services platform. It represents the dominant incumbent in pharmacy benefit management that SHARx's transparent, flat-fee approach is designed to displace at self-funded employers.
• MedImpact Healthcare Systems: MedImpact is an independent, primarily pass-through PBM that serves health plans and self-funded employers. It competes broadly with SHARx in the specialty and commercial PBM space while operating at larger scale across more benefit designs.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights7 records

Customer concentration

• YouTubeyoutube.com/channel/UCG8VEK_2ZiPBn7C2YxMee7g
• Facebookfacebook.com/sharx.llc
• LinkedInlinkedin.com/company/52185605
• Instagraminstagram.com/sharxllc

Compliance1 record

Revenue estimate

Valuation estimate

Number of profiles

Profiles4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about SHARx